Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Epigenetics|September 6, 2013
Functional epigenetic approach identifies frequently methylated genes in Ewing sarcomaAbdullah Alholle, Anna T Brini, Seley Gharanei, et al.World Journal of Surgical Oncology|September 21, 2018
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of boneJacob Engellau, Leanne Seeger, Robert Grimer, et al.The Lancet. Oncology|July 23, 2013
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 studySant Chawla, Robert Henshaw, Leanne Seeger, et al.European Journal of Cancer (Oxford, England : 1990)|May 14, 2016
Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G groupStéphanie Foulon, Bernadette Brennan, Nathalie Gaspar, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 14, 2018
Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trialPiotr Rutkowski, Louie Gaston, Aneta Borkowska, et al.Journal of the National Cancer Institute|January 18, 2007
Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma IntergroupIan J Lewis, Marianne A Nooij, Jeremy Whelan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patientsMichael Paulussen, Alan W Craft, Ian Lewis, et al.European Journal of Cancer (Oxford, England : 1990)|December 23, 2014
Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society studyAnna Maria Frezza, Marilena Cesari, Daniel Baumhoer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Ewing Sarcoma: Current Management and Future Approaches Through CollaborationNathalie Gaspar, Douglas S Hawkins, Uta Dirksen, et al.European Journal of Cancer (Oxford, England : 1990)|January 28, 2019
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohortSigbjørn Smeland, Stefan S Bielack, Jeremy Whelan, et al.Pageof 6